FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313252616> ?p ?o ?g. }

• W4313252616 endingPage "334" @default.
• W4313252616 startingPage "327" @default.
• W4313252616 abstract "BackgroundVancomycin is commonly used to treat methicillin-resistant staphylococcal infections in neonates. Consensus on its ideal dosing in neonates has not been achieved. Model-based dosing recently has evolved as an important tool to optimize vancomycin initial dosing. The aim of this is to evaluate a population pharmacokinetic model-based approach in achieving the vancomycin therapeutic target of an AUC0-24 400 as recommended by the recent IDSA treatment guidelines. This model was implemented as a simple Excel calculator to individualize and optimize vancomycin initial dosing in neonates.MethodsAn Excel calculator was developed using a previously published population pharmacokinetic model in neonates. It was evaluated using retrospectively retrieved data. For each patient, the initial empiric dose was calculated using the proposed Excel model and the most widely used neonatal dosing references. The probability of achieving the target AUC0–24 of >400 mg h/L using the model-based method was calculated and compared with that of the empiric doses using other references.ResultsThis analysis included 225 neonates. The probability of achieving the target AUC0–24 >400 was 89% using our model-based approach compared with 11%–59% using tertiary neonatal dosing references (p < 0.01 for all comparisons).ConclusionThese innovative personalized dosing calculators are promising to improve vancomycin initial dosing in neonates and are easily applicable in routine practices. Vancomycin is commonly used to treat methicillin-resistant staphylococcal infections in neonates. Consensus on its ideal dosing in neonates has not been achieved. Model-based dosing recently has evolved as an important tool to optimize vancomycin initial dosing. The aim of this is to evaluate a population pharmacokinetic model-based approach in achieving the vancomycin therapeutic target of an AUC0-24 400 as recommended by the recent IDSA treatment guidelines. This model was implemented as a simple Excel calculator to individualize and optimize vancomycin initial dosing in neonates. An Excel calculator was developed using a previously published population pharmacokinetic model in neonates. It was evaluated using retrospectively retrieved data. For each patient, the initial empiric dose was calculated using the proposed Excel model and the most widely used neonatal dosing references. The probability of achieving the target AUC0–24 of >400 mg h/L using the model-based method was calculated and compared with that of the empiric doses using other references. This analysis included 225 neonates. The probability of achieving the target AUC0–24 >400 was 89% using our model-based approach compared with 11%–59% using tertiary neonatal dosing references (p < 0.01 for all comparisons). These innovative personalized dosing calculators are promising to improve vancomycin initial dosing in neonates and are easily applicable in routine practices." @default.
• W4313252616 created "2023-01-06" @default.
• W4313252616 creator A5022849781 @default.
• W4313252616 creator A5034656371 @default.
• W4313252616 creator A5053044973 @default.
• W4313252616 creator A5063843479 @default.
• W4313252616 creator A5071488303 @default.
• W4313252616 creator A5088400581 @default.
• W4313252616 date "2023-05-01" @default.
• W4313252616 modified "2023-09-26" @default.
• W4313252616 title "Evaluation of vancomycin individualized model-based dosing approach in neonates" @default.
• W4313252616 cites W1949023840 @default.
• W4313252616 cites W1974280087 @default.
• W4313252616 cites W2044599763 @default.
• W4313252616 cites W2052264066 @default.
• W4313252616 cites W2072388239 @default.
• W4313252616 cites W2076436303 @default.
• W4313252616 cites W2088643021 @default.
• W4313252616 cites W2088996598 @default.
• W4313252616 cites W2101779653 @default.
• W4313252616 cites W2106354296 @default.
• W4313252616 cites W2108433768 @default.
• W4313252616 cites W2109144391 @default.
• W4313252616 cites W2118509587 @default.
• W4313252616 cites W2119259412 @default.
• W4313252616 cites W2134944593 @default.
• W4313252616 cites W2335461277 @default.
• W4313252616 cites W2560228642 @default.
• W4313252616 cites W2562884911 @default.
• W4313252616 cites W2565570250 @default.
• W4313252616 cites W2587355458 @default.
• W4313252616 cites W2626474456 @default.
• W4313252616 cites W2742565536 @default.
• W4313252616 cites W2755460346 @default.
• W4313252616 cites W2779056775 @default.
• W4313252616 cites W2790301804 @default.
• W4313252616 cites W2951986264 @default.
• W4313252616 cites W2999556785 @default.
• W4313252616 cites W3012260518 @default.
• W4313252616 cites W3024869617 @default.
• W4313252616 cites W3080661741 @default.
• W4313252616 cites W3111752688 @default.
• W4313252616 cites W3129921430 @default.
• W4313252616 doi "https://doi.org/10.1016/j.pedneo.2022.10.006" @default.
• W4313252616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36581523" @default.
• W4313252616 hasPublicationYear "2023" @default.
• W4313252616 type Work @default.
• W4313252616 citedByCount "1" @default.
• W4313252616 countsByYear W43132526162023 @default.
• W4313252616 crossrefType "journal-article" @default.
• W4313252616 hasAuthorship W4313252616A5022849781 @default.
• W4313252616 hasAuthorship W4313252616A5034656371 @default.
• W4313252616 hasAuthorship W4313252616A5053044973 @default.
• W4313252616 hasAuthorship W4313252616A5063843479 @default.
• W4313252616 hasAuthorship W4313252616A5071488303 @default.
• W4313252616 hasAuthorship W4313252616A5088400581 @default.
• W4313252616 hasBestOaLocation W43132526161 @default.
• W4313252616 hasConcept C111919701 @default.
• W4313252616 hasConcept C112705442 @default.
• W4313252616 hasConcept C126322002 @default.
• W4313252616 hasConcept C177713679 @default.
• W4313252616 hasConcept C2776836400 @default.
• W4313252616 hasConcept C2777288759 @default.
• W4313252616 hasConcept C2778980435 @default.
• W4313252616 hasConcept C2779489039 @default.
• W4313252616 hasConcept C2780272996 @default.
• W4313252616 hasConcept C2908647359 @default.
• W4313252616 hasConcept C41008148 @default.
• W4313252616 hasConcept C523546767 @default.
• W4313252616 hasConcept C54355233 @default.
• W4313252616 hasConcept C71924100 @default.
• W4313252616 hasConcept C86803240 @default.
• W4313252616 hasConcept C99454951 @default.
• W4313252616 hasConceptScore W4313252616C111919701 @default.
• W4313252616 hasConceptScore W4313252616C112705442 @default.
• W4313252616 hasConceptScore W4313252616C126322002 @default.
• W4313252616 hasConceptScore W4313252616C177713679 @default.
• W4313252616 hasConceptScore W4313252616C2776836400 @default.
• W4313252616 hasConceptScore W4313252616C2777288759 @default.
• W4313252616 hasConceptScore W4313252616C2778980435 @default.
• W4313252616 hasConceptScore W4313252616C2779489039 @default.
• W4313252616 hasConceptScore W4313252616C2780272996 @default.
• W4313252616 hasConceptScore W4313252616C2908647359 @default.
• W4313252616 hasConceptScore W4313252616C41008148 @default.
• W4313252616 hasConceptScore W4313252616C523546767 @default.
• W4313252616 hasConceptScore W4313252616C54355233 @default.
• W4313252616 hasConceptScore W4313252616C71924100 @default.
• W4313252616 hasConceptScore W4313252616C86803240 @default.
• W4313252616 hasConceptScore W4313252616C99454951 @default.
• W4313252616 hasFunder F4320322997 @default.
• W4313252616 hasIssue "3" @default.
• W4313252616 hasLocation W43132526161 @default.
• W4313252616 hasLocation W43132526162 @default.
• W4313252616 hasOpenAccess W4313252616 @default.
• W4313252616 hasPrimaryLocation W43132526161 @default.
• W4313252616 hasRelatedWork W1524446842 @default.
• W4313252616 hasRelatedWork W2080176316 @default.
• W4313252616 hasRelatedWork W2119916599 @default.

• next